Neuralstem, Inc. (NASDAQ:CUR) shares passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.32 and traded as high as $1.81. Neuralstem shares last traded at $1.52, with a volume of 2,096,500 shares changing hands.
Separately, ValuEngine upgraded Neuralstem from a “hold” rating to a “buy” rating in a research note on Wednesday, July 31st.
The firm has a 50-day simple moving average of $1.42 and a two-hundred day simple moving average of $1.34.
Neuralstem, Inc, a clinical stage biopharmaceutical company, focuses on the research and development of nervous system therapies based on its proprietary human neuronal stem cells and small molecule compounds. The company's stem cell based technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons of various types.
Recommended Story: Capital Gains
Receive News & Ratings for Neuralstem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuralstem and related companies with MarketBeat.com's FREE daily email newsletter.